In Boston, 908 Devices Inc. announced their financial results for the quarter ending September 30, 2025. The company, traded under Nasdaq as MASS, specializes in handheld chemical analysis tools for health, safety, and defense technology purposes. CEO and Co-founder Kevin J. Knopp expressed satisfaction with their progress so far in the year, highlighting efforts to establish a more stable and lucrative business model and advance their 908 Devices 2.0 vision. Specific revenue numbers were not disclosed.